“Upstart” e-cigarette makers are vying to get their products prescribed on the NHS, as they target a potentially lucrative new market before Big Tobacco commits to the lengthy licensing process, the Financial Times reports.
“Upstart” e-cigarette makers are vying to get their products prescribed on the NHS, as they target a potentially lucrative new market before Big Tobacco commits to the lengthy licensing process, the Financial Times reports.